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Abstract Adenosine 5'-tetraphosphate (Ap4) is a natural 
constituent of chromaff'm granules with concentration values of 
2.2 + 0.1 nmol/mg of protein and a ratio 245 + 40 times lower 
with respect to ATP (!! = 4). The granular transport of E-ATP 
resulted in a time- and concentration-dependent production of 
~-adenosine tetraphosphate (E-Ap4) at the intragrannlar level. 
The ~-Ap4 formation followed a hyperbolic saturation kinetic at 
low ~-ATP concentrations with Km value of 0.4 I~M E-ATP 
intragranular (1.15 pmol/mg of granular protein). Intragranular 
concentrations of ~-ATP higher than 500 pmol/mg of protein 
( = 175 lxM intragranular) resulted in a non-saturable production 
of E-Ap4. 
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1. Introduction 
ATP is the most abundant currently reported nucleotide 
stored in synaptic vesicles and secretory granules; smaller, 
although significant, amounts of a large variety of other nu- 
cleotidic compounds uch as ADP, AMP, GTP, UTP and 
very small amounts of adenosine 5'-tetraphosphate (Ap4) 
have also been found in diverse secretory organelles [1,2]. 
Moreover, the presence of diadenosine polyphosphates, 
Ap4A, ApsA and AprA, has also been reported in catechol- 
aminergic hromaffin granules and cholinergic vesicles from 
Torpedo electric organ, which are among the best character- 
ized storage vesicles and can provide evidence about the com- 
plexity and richness of nucleotidic ontent in other neural or 
endocrine models [3-5]. 
The presence of such a large variety of nucleotides and 
dinucleotides in neural storage granules is mostly due to the 
low specificity of the transport process. The vesicular nucleo- 
tide transporter exhibits similar affinity values for all nucleo- 
tides triphosphate and nucleotides diphosphate (NTP and 
NDP) [6,7]. In contrast o its low specificity, the nucleotide 
vesicular transporter appears to be highly regulated by the 
cytosolic concentration of nucleotides [8]. 
Intragranular transphosphorylation between nucleotides 
has also been reported and it is to be considered when study- 
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ing the granular content [6,9]. This phenomenon became evi- 
dent when the transport studies were carried out with the 
fluorescent 1,N~-ethenoderivative of ADP (e-ADP), which 
once internalized to chromaffin granules was recovered mostly 
as e-ATP [8]. 
Formation of e-adenosine tetraphosphate ( -Ap4) in chro- 
maffin granules, after e-ATP transport, is reported in this 
study. The data presented here can explain the presence of 
Ap4 in chromaffin granules and give physiological supplement 
to recent data showing that Ap4 is a more effective agonist 
than ATP on the P2x purinoceptors present on guinea-pig vas 
deferens [10]. 
2. Materials and methods 
2.1. Preparation of chromaffin granules 
Purified chromaffin granules were obtained following the method 
reported by Rodriguez del Castillo et al. [3], with some modifications 
directed to obtain granular preparations with high purity and in the 
best conditions to carry out the transport experiments. The buffer 
employed throughout the experimental procedure was 0.3 M sucrose 
containing 50 ~tM phenylmethylsulphonyl fluoride, 2 mM EDTA, 1 
mM dithiotreitol, and 10 mM 1,4-piperazinediethanesulfonic ac d 
(PIPES), pH 6.0 (buffer A) [8]. 
Granular preparations tomeasure Ap4 levels were resuspended in 1 
ml of water per each gram of original tissue, submitted to two freeze- 
thaw cycles and centrifuged at 100000×g for 10 min. Routinely, 
samples between 2 and 5 ~tl were taken for processing by HPLC. 
2.2. Transport experiments 
The transport experiments were performed with etheno-ATP (e- 
ATP) as substrate and carried out with 100 ktl of the granular pre- 
paration which corresponded to 0.1 g of the original adrenomedulary 
tissue resuspended in a buffer containing 0.3 M sucrose, 5 mM 
MgC12, and 10 mM Tris-HC1, pH 7.2 (buffer B). The experimental 
procedure for saturation- and time-dependent transport studies was 
carried out according to the method of Gualix et al. [8]. After the 
transport experiments the pellet, to measure the intragranular E-nu- 
cleotides, was resuspended in 1 ml of a mixture of 0.1 ml of ethanol 
and 0.9 ml of the HPLC buffer (described below). The granular sus- 
pension was submitted to a freeze-thaw cycle and then centrifuged at 
100000xg for 30 rain. The samples were stored at -80°C until the 
process by HPLC. 
2.3. HPLC procedures 
The chromatografic equipment was from Waters and consisted of a 
600E delivery system, an injector Autosampler 717 Plus, a Scanning 
fluorescent detector 474 and a Millenium 2010 Chromatography Man- 
ager System. The separation of the nucleotides and e-nucleotides was 
performed using ion pair chromatography [11]. The mobile phase 
contained 10 mM KH2PO4, 2 mM tetrabutyl ammonium and 15% 
acetonitrile, pH 7.5. The column used was a Nova-Pak C-18 from 
Waters and, in some experiments, an RSiL C18 HL column from 
Bio-Rad. The eluents from the column were excited at 306 nm and 
the emission was recorded at 410 nm for all e-nucleotides [12,13]. The 
peak areas were transformed to concentrations by correlation with 
commercial standards of nucleotides and e-nucleotides (Sigma, St. 
Louis, Mo). E-Ap4 was synthesized by condensation of Ap4 with 
chloroacethaldehyde as described for the e-diadenosine polyphos- 
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phates [13] and purified by HPLC under the same lution conditions 
as described above. Non-fluorescent nucleotides were detected using a 
Xmax 481 Spectrophotometer (Waters) at 260 nm wavelength. 
3. Results 
3.1. Presence of Ap4 and e-Ap4 in chromaffin granules 
The presence of Ap4 as a natural constituent of chromaffin 
granules, already reported by other authors, was confirmed 
[1]. The concentration values obtained in our preparations 
were 2.2-+ 0.1 nmol/mg of protein and a ratio with respect 
to ATP of 245 + 40 times lower (n=4). Fig. IA shows a typical 
chromatogram of the chromaffin granule nucleotide content. 
The Ap4 was identified by the retention time and coelution 
with extemal standard. The elution conditions described were 
necessary to obtain a sharper Ap4 peak. 
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Fig. l. E-Ap4 production and Ap4 presence in chromaffin granules. 
(A) Detection of Ap4 in chromallin granules lysate: measurement of 
Ap4 in chromaffm granules was carried out as described in Section 
2. The HPLC profile corresponding to the chromatiin granules ly- 
sate are represented in the figure. Presence of an Ap4 peak was con- 
firmed by the addition to the lysate of an external standard. In this 
case, the first part of the chromatogram was deleted to avoid over- 
crowding the figure. (B) Formation of e-Ap4 as a function of time 
in chromaffin granules incubated with E-ATP: samples of chromaffm 
granules containing 0.38 mg of protein were incubated in the pres- 
ence of 6 mM e-ATP as described in Section 2. The overlayed chro- 
matograms in the figure correspond to the e-nucleotide content, in 
the granular pellet, after incubation periods of 0 min, 10 rain, 30 
min, 1 h and 2 h. The fluorescence of e-nucleotide peaks is ex- 
pressed in arbitrary units. In A and B, the HPLC column employed 
was a Novapak C-18 cartridge. 
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Fig. 2. HPLC chomatograms showing the appearance of E-Ap4 in 
chromaffin granules incubated with several concentrations of e-ATP. 
Samples of chromaffin granules containing 0.38 mg of protein were 
incubated in the presence of e-ATP concentrations ranging from 
150 ~tM to 6 mM for 10 min, as described in Section 2. The conse- 
cutive chromatograms in the figure correspond to the chromatogra- 
fic profiles obtained for the granular pellets after incubation with e- 
ATP concentrations of 0.15, 0.2, 0.3, 0.4, 0.6, 0.8, l, 1.2, 1.6 and 2 
raM. Chromatograms for higher concentrations were omitted in or- 
der to avoid a crowded figure. Chromatografic profiles were ob- 
tained using an RSiL C18 HL column. 
were carried out to characterize the nucleotide vesicular trans- 
port employing e-ATP. The HPLC chromatograms showed 
that, although most of the nucleotide once internalized re- 
mained as e-ATP, a significant part appeared as e-ADP and 
e-AMP. When the HPLC eluates were allowed to flow for 
longer periods of time, another fluorescent compound became 
evident, as shown in Fig. lB. The longer time of retention 
suggested the existence of a more phosphorylated nucleotide. 
The presence of e-Ap4A or e-ApsA was ruled out because the 
peak was destroyed by treatment with alkaline phosphatase 
(results not shown). Comparison with e-Ap4 standard resulted 
in coelution of both compounds and the peak was identified 
as the e-adenosine 5'-tetraphosphate. The intragranular e-Ap4 
levels increased up to 30 min incubation time, although the 
lineal period was considerably reduced. Experimental times of 
10 min transport for the concentration dependence studies 
were routinely employed. No production of e-Ap4 was ob- 
served in the incubation media. 
3.2. Intragranular e-Ap4 production in relation to e-ATP 
The HPLC distribution profiles of e-nucleotides inside the 
chromaffin granules, after 10 min incubation time, with vari- 
able extragranular concentrations of E-ATP are shown in Fig. 
2. The internal concentrations of e-Ap4 under 150 ~tM extra- 
granular e-ATP resulted in a very small production of the 
nucleotide, which was difficult to quantify accurately. 
The presence of e-Ap4 in the granule was dependent on that 
of e-ATP. When production of e-Ap4 was plotted versus the 
intragranular e-ATP concentrations, a biphasic urve was ob- 
tained (Fig. 3A). The first part of the curve, at low intragra- 
nular concentrations of e-ATP, shows the production of 
e-Ap4 that appeared to follow a saturable kinetic. The second 
part corresponds to intragranular concentrations larger than 
500 pmol/mg protein of e-ATP, obtained when extragranular 
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Fig. 3. Saturation studies of £-Ap4 formation as a function of the 
intragranular e-ATP concentration. (A) Michaelis-Menten represen- 
tation of intragranular e-Ap4 versus intragranular e-ATP. (B) 
Hanes-Woolf representation f the intragranular e-ATP/e-Ap4 ratio 
versus intragranular e-ATP. Concentration values are means of 
three saturation-dependence transport experiments uch is repre- 
sented in Fig. 2. The standard eviation did not exceed, in any 
case, + 15% of the mean values. 
concentrations, in transport experiments, were higher than 1.2 
mM for the same nucleotide. This part of the curve appeared 
to follow a non-saturable kinetic. 
The Hanes-Woolf plot from Fig. 3B allows a direct repre- 
sentation of the intragranular ratio of e-ATP/e-Ap4 (S/V) ver- 
sus the intragranular e-ATP (S) [14]. The shape of the curve 
indicates more clearly the existence of the biphasic process 
already suggested and allows the kinetic parameters to be 
obtained more easily. The e-Ap4 formation was more favour- 
able at the lowest concentrations of e-ATP and continuously 
declined until reaching the second part of the curve where a 
ratio of 18 times more e-ATP than e-Ap4 was obtained. This 
proportion was maintained constant in the broad range of 
e-ATP concentrations used, reaching 6 mM extragranular. 
The Km value for the saturation component required the pre- 
sence of 1.15 pmol e-ATP intragranular/mg of total granular 
proteins. The Vm~ value obtained for the e-Ap4 production 
was 29 pmol/mg protein for the saturable component. 
4. Discussion 
The results presented here show the production of e-Ap4 
after vesicular transport of E-ATP and confirmed the already 
reported presence of Ap4 as a natural constituent of the chro- 
maffin granules [1]. 
The Ap4 values reported here indicate a granular concen- 
tration close to 0.8 mM, taking into account a 245 times ATP/ 
Ap4 ratio and the granular concentration reported in the lit- 
erature for the ATP. One explanation for the granular Ap4 
presence could be the low selectivity of the nucleotide vesicu- 
lar transporter conceming the phosphate number [2,6,8]. An- 
other could be the Ap4 formation by phosphate interchange 
among granular nucleotides [6,8,9] according to the results 
reported here with e-ATP. 
The e-Ap4 formation is dependent on the intragranular 
presence of e-ATP, exhibiting a well-defined kinetic. The Km 
value for the saturable component is 0.4 I.tM when the intra- 
granular e-ATP concentration is considered. Moreover, it is 
necessary to point out that the e-ATP values reported here 
correspond to the end of the transport period, and the Km 
value could be significantly lower. The affinity for the natural 
substrate, ATP, would be similar to E-ATP based on structur- 
al analogy. 
The non-saturable component of e-Ap4 formation requires 
intragranular concentration higher than 175 I.tM for e-ATP, 
and the quotient value for e-ATP/e-Ap4 is maintained at 
around 18 in a very large range of concentrations. A higher 
ratio (ATP/Ap4=245) was obtained for the natural nucleotides 
in mature chromaffin granules. The saturable component, 
working at very low substrate concentrations, needs to be 
considered in immature granules or in synaptic vesicles that 
have undergone replenishment after exocytosis. In this situa- 
tion, the Ap4 could not be a scarce vesicular constituent, and 
its actions could be physiologicaly relevant. The Ap4 has been 
reported to be one order of magnitude more active than the 
ATP and its non-hydrolyzable analogues in the induction of 
contractions in guinea-pig vas deferens mediated by P2x recep- 
tors [101. 
An additional source of Ap4 at the extracellular level is the 
action of ecto-diadenosine polyphosphate hydrolase on diade- 
nosine pentaphosphate (ApsA), released from secretory gran- 
ules, that produces AMP and Ap4. 
The fact that the Ap4 is a poor substrate for the ecto-nu- 
cleotidases cascade allows its extracellular accumulation for 
longer periods of time and possible interaction with P2 pur- 
inoceptors [15]. Although much work is necessary for a com- 
plete understanding of Ap4 actions on cellular signaling, its 
role in the global context of purinergic transmission cannot be 
overlooked. 
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